Mi-So Jeong | Cancer Biology | Best Researcher Award

Published on by Life Science

Dr. Mi-So Jeong | Cancer Biology | Best Researcher Award

Dong-A University | South Korea

Dr. Mi-So Jeong is an active and highly productive cancer biology researcher with a strong publication record centered on bladder cancer genomics, chemoresistance, molecular biomarkers, and tumor progression mechanisms. Her work includes first-author publications in influential journals such as Clinical and Translational Medicine, Cancer Letters, Genes (Basel), Cell Death Discovery, and Genes & Genomics, demonstrating consistent leadership in molecular cancer research. Her studies have identified novel liquid biopsy markers, dissected chemoresistance-associated evolutionary signatures, and clarified genomic variants linked to bladder cancer susceptibility. She has contributed important insights into regulatory pathways involving E2F1, FOXM1, RAD54L, VNTR polymorphisms, CAF-induced migration, and SERPINE1-mediated metastasis, while also participating in multi-institutional programs investigating tumor immunity, molecular repair pathways, and signaling-driven disease recurrence. Her research expands further into breast cancer imaging genomics, hypertension-related VNTR variants, tumor microenvironment regulation, and metastatic signaling. With h-index 8,  18 total documents publications, and 192 citation count citations, together with repeated first-author contributions across high-impact outputs, Mi-So Jeong demonstrates a strong trajectory of scientific advancement.

Profile: Scopus 

Featured Publications

Jeong, M. S., Mun, J. Y., Yang, G. E., Baek, S. W., Lee, S. Y., Yun, S. H., Kim, S. I., Kim, J. J., Yoon, S. Y., Nam, J. K., Choi, Y. H., Goh, H. J., Kim, T. N., & Leem, S. H. Lipocalin 2 as a potential liquid biopsy marker for early detection of bladder cancer. Clinical and Translational Medicine.

Jeong, M. S., Baek, S. W., Yang, G. E., Mun, J. Y., Kim, J. A., Kim, T. N., Nam, J. K., Choi, Y. H., Lee, J. S., Chu, I. S., & Leem, S. H. Chemoresistance-motility signature of molecular evolution to chemotherapy in non-muscle-invasive bladder cancer and its clinical implications. Cancer Letters, 610, 217339.

Eum, D. Y., Lee, C., Tran, C. S., Lee, J., Park, S. Y., Jeong, M. S., Jin, Y., Shim, J. W., Lee, S. R., Koh, M., Mishchenko, N. P., Park, S. J., Choi, S. H., Choi, Y. J., Yun, H., & Heo, K. (2024). Regulatory role of Echinochrome A in cancer-associated fibroblast-mediated lung cancer cell migration. Toxicological Research, 40(3), 409–419.

Yang, G. E., Kim, M. H., Jeong, M. S., Lee, S. Y., Choi, Y. H., Nam, J. K., Kim, T. N., & Leem, S. H. Association between PDCD6-VNTR polymorphism and urinary cancer susceptibility. Genes & Genomics, 46(11), 1281–1291.

Jeong, M. S., Mun, J. Y., Yang, G. E., Kim, M. H., Lee, S. Y., Choi, Y. H., Kim, H. S., Nam, J. K., Kim, T. N., & Leem, S. H. Exploring the relationship between CLPTM1L-MS2 variants and susceptibility to bladder cancer. Genes, 15(1), 50.